Ranbaxy Laboratories Limited
News and overview for Ranbaxy Laboratories Limited
Ranbaxy Launches Authorized Generic Version of Rocaltrol(R) [Press Release]
PRNewswire | 83 days 20 hours 43 minutes ago
...wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India...wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest...healthcare system. Ranbaxy Laboratories Limited, headquartered in India...
Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets [Press Release]
PRNewswire | 105 days 18 hours 14 minutes ago
...wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today...wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest...healthcare system. Ranbaxy Laboratories Limited, headquartered in India...
Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets [Press Release]
PRNewswire | 92 days 16 hours 44 minutes ago
...wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today...wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest...healthcare system. Ranbaxy Laboratories Limited, headquartered in India...
Generic Pharmaceutical Partner Jay Deshmukh Joins Knobbe Martens D.C. Office [Press Release]
Business Wire | 15 days 14 hours 9 minutes ago
Jay R. Deshmukh has joined Knobbe Martens Olson & Bear, LLP as a partner in the firm’s Washington D.C. office. He will focus his practice on generic pharmaceutical counseling and litigation.
Reportlinker Adds Prescription Drugs Report [Press Release]
PRNewswire | 77 days 17 hours 13 minutes ago
...players worldwide such as Abbott Laboratories, Allergan, Inc., Amgen...Ingelheim Group, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company...Novartis AG, Pfizer, Inc., Ranbaxy Laboratories Limited, Sanofi-Aventis SA, Sanofi...
Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of CLARINEX(R) [Press Release]
PRNewswire | 105 days 9 hours 14 minutes ago
...s Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., GeoPharma, Inc., Glenmark Pharmaceuticals...Inc., Perrigo Co., L. Perrigo, Co., Ranbaxy Inc., Ranbaxy Laboratories Limited, Sandoz Inc., Sun Pharmaceutical Industries...
Research and Markets' extensive and objective analysis on the Asia-Pacific pharma market
News-Medical.Net | 11 days 22 hours 19 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/e201bb/asia_pacific_pharm) has announced the addition of the "Asia Pacific Pharma Sector Analysis" report to their offering.
Research and Markets: This Essential Report Analyzing the Global Pharmaceutical Industry is Now Available [Press Release]
Business Wire | 40 days 16 hours 42 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/a9d8ff/analyzing_the_glob) has announced the addition of the "Analyzing the Global Pharmaceutical Industry" report to their offering.
Ranbaxy recalls drugs for skin disease from US
Financial Express (India), The | 4 days 20 hours 16 minutes ago
Ranbaxy Laboratories has recalled from the US market a batch of 4,348 cartons of Sotret Isotretinoin capsules used in treating skin infections.
PPD Announces Plans to Spin off Compound Partnering Business [Press Release]
Business Wire | 28 days 10 hours 43 minutes ago
PPD, Inc. (Nasdaq: PPDI) today announced its board of directors has authorized management to proceed with preparations to spin off its compound partnering business from its core contract research organization, or CRO, business.
Strong Yen Slows Japanese Drug Firms' Recovery
Wall Street Journal, The | 23 days 7 hours 33 minutes ago
TOKYO—Three of Japan's top pharmaceutical companies reported profit gains following aggressive acquisitions, but the strong yen damped their earnings recovery.
OCTOBER 30, 2009, 7:56 A.M. ET Strong Yen Slows Japanese Drug Firms' Recovery
Barron's (subscription required) | 25 days 19 hours 11 minutes ago
TOKYO—Three of Japan's top pharmaceutical companies reported profit gains following aggressive acquisitions, but the strong yen damped their earnings recovery.
India stx up 1 pct, Larsen gains after share sale
Forbes | 11 days 23 hours 56 minutes ago
BANGALORE, Nov 13 (Reuters) - Indian shares rose more than 1 percent despite a choppy morning session on Friday, helped by gains made by infrastructure play Larsen & Toubro after the firm sold off a third of its stake in outsourcing firm Mahindra Satyam.
13 Results
Sign up for FDLI SmartBrief
Company Overview
| Company: | Ranbaxy Laboratories Limited |
|---|---|
| Industry: | Generic Drugs |
| Website: | http://www.ranbaxy.com |
Ranbaxy Laboratories is quite the rainmaker in India's pharmaceutical business. The company is India's largest drug manufacturer, as well as a top global generics producer. Anti-infectives amoxycillin and ciprofloxacin, and cardio drug simvastatin are among Ranbaxy's top sellers; all come in several administration forms. The company also addresses gastrointestinal, musculoskeletal, and central nervous system disorders, as well as diabetes, pain, allergies, and HIV/AIDS. Its R&D focus includes new forms of existing drugs and metabolic disease treatments. The company also has a groundbreaking anti-malarial candidate in late-phase trials. Japanese drugmaker Daiichi Sankyo owns a controlling stake in Ranbaxy.
Key Numbers
| Sales in U.S. Dollars (mil.) | 943.6 (2008) |
|---|---|
| One-year % Growth in Sales | 0.0 (2008) |
| Net Income in U.S. Dollars (mil.) | 0 () |
| One-year % Growth in Net Income | 0.0 () |
| Number of Employees | 12,174 (2008) |
| One-year % Growth in Number of Employees | 0.0 (2008) |
| Fiscal Year-End | December |